Read more: Evidation Raises $153M to Scale Virtual Health Capabilities of Achievement Platform

Our Products

Generating Evidence and Motivating Evidence-Based Action

Evidation is a two-sided platform connecting individuals and enterprises. On the consumer side, we provide value to over 4 million individuals (Achievers) across the US who are highly motivated to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, medtech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.

Evidation pioneered the use of person-generated health data (PGHD), coining the term itself. We recognized that the vast majority of an individual’s lived health experience is outside of a medical facility, and yet most clinicians and researchers fly blind to this aspect of an individual.

Defining Person-Generated Health Data by Evidation.

Evidation's network of Achievers are highly motivated to participate in managing their health. We complement their active engagement with the passive monitoring of consumer wearables and apps, at their behest and with their consent.

The Evidation Platform provides an end-to-end value proposition to enterprises in reducing the latency in moving from evidence to action that results in individuals getting on the right evidence-supported treatment quickly. We provide education, coaching, and wellness education - we do not practice medicine or provide health care services.

0.03% Visible: RWE data, episodic. 99.97% invisible: PGHD, continuous, passive.

Generating Evidence

Evidation conducts projects for enterprises to get actionable evidence in three areas: disease burden and patient impact, patient segmentation and identification, disease event and progression modeling. We deploy a proven approach, incorporating our experience doing over 200 studies, that reliably delivers results. Given our connectivity with highly engaged individuals, we deliver faster and more cost-effectively.

Disease Burden and Patient Impact

Understand and quantify the impact of disease on patients’ quality of life (QOL) and activities of daily living (ADL).

Case study

Evidation conducted the first study to assess the everyday impact of constipation, a commonly overlooked condition. Through our Achievement app, our team recruited over 1,500 individuals with lower gut health issues and had high compliance rates with an intensive 12-week study protocol. In under one year, we delivered results which have the potential to get more patients on the right treatment faster.

Chart describing the case study.



Patient Segmentation & Identification

Identify and segment patients based on real world behaviors and disease impact.

Case study

Using PGHD, we could identify patients whose asthma symptoms were not adequately managed on current treatments. In one week, Evidation recruited over 14,000 individuals with asthma via our Achievement population and delivered results in under 12 weeks. For two patients below who appear identical in claims data – the same diagnosis (moderate-to-severe asthma) and treatment (LABA/ICS) – with PGHD, we can identify that one patient’s asthma is not suitably controlled on existing treatment. Similarly, we see clear splits in activity sleep behaviors that may indicate how well controlled a patient’s asthma is. These findings enable early identification of individuals  with inadequate symptom control, who could benefit from treatment.

Chart describing the case study.



Disease Event & Progression Modelling

Use PGHD to detect and predict disease events and changes in health status and measure progression and recovery over time.

Case study

Through PGHD, Evidation detected and measured the impact of flares in an autoimmune condition. We were able to detect flares through measured changes in behavior and quantify flare impact and recovery over time. This foundation has the potential to help accelerate time to diagnosis and getting patients on the right treatment faster.

Chart showing case study data.



Motivating Evidence-Based Action

Our product enables enterprises to design, test, and deploy digital programs (on our Achievement network) to motivate individuals to engage in their health, in a measurable way. Evidation offers enterprises subscription-based access to specific cohorts—for example individuals managing heart conditions such as heart failure, dyslipidemia, hypertension, atrial fibrillation—to validate how to engage the right individuals and motivate the right action at the right time.
Our platform allows enterprises to identify the right individual who could benefit from engagement, nudge the members of the target group towards the right evidence-supported next action, and measure the results. 

Identify the right patients

Using signals from devices, data from apps, and PROs


Individuals with worsening symptoms, such as a HF patient with sudden weight gain

Nudge on the right action

Applying test-and-learn approach, building on behavior nudging theory


Prompts to read materials to manage symptoms, alerts to engage clinician when weight spikes exceed guidelines

Measure action and outcome

Enabling continuous improvement and proving return on investments


Engagement measure (retention, clicks), action measure (outreach to clinician, report taken to clinician)

Flu example

For Sanofi, Evidation identified 30,000 individuals with type 2 diabetes, at high-risk for the flu. We nudged this population in a variety of ways to obtain the flu vaccine, resulting in a measurable increase in vaccination rates relative to those we did not engage.

Further Reading

Atrial Fibrillation example

Evidation is working with J&J and Apple to improve diagnosis/treatment rates and outcomes for atrial fibrillation. We identify at-risk individuals, engage through tailored insights, and nudge to contact clinicians to get appropriate care sooner.

Further Reading

Our product is available in these therapeutic areas: cardiovascular, respiratory, autoimmune, central nervous system, and infectious disease. Evidation has joined forces with the American College of Cardiology in heart health, and are investing in research and toolkits to support individuals with a heart failure diagnosis.

Learn More

1.2M research participants. 720M daily data collected. >40% response rate to research offers. 85% project compliance.

As of Jan. 2021

The Evidation difference

The Evidation Platform offers a one-stop value proposition to enterprises to dramatically reduce latency in getting from evidence to action, in a measurable manner. We are able to begin testing—clinical hypotheses for researchers/medical, nudge/behavior patient engagement propositions for marketers, as well as digital tooling for the digital leads—almost instantly and thereby reducing significant waste. We are able to do this as we have over 4 million highly-engaged individuals on our platform.

We help enterprises address one of the most common sources of failure in building and testing patient programs and digital engagement solutions – getting critical mass of patients to engage early and often.

Contact Us

Accelerating Research With Technology: Rapid Recruitment for a Large-Scale Web-Based Sleep Study

by Evidation